QuidelOrtho Corporation (QDEL) compared with its closest peers (NEOG, MYGN, FTRE, MEDP, NTRA). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Neogen and Myriad Genetics share QuidelOrtho's sub-industry, diagnostics makers.
| Company | Market Cap | P/E |
|---|---|---|
| Neogen Corporation (NEOG) | $2.54B | -224.1 |
| Myriad Genetics, Inc. (MYGN) | $308.95M | -1.6 |
| Fortrea Holdings Inc. (FTRE) | $1.77B | -1.6 |
| Medpace Holdings, Inc. (MEDP) | $16.56B | 33.7 |
| Natera, Inc. (NTRA) | $47.18B | -150.7 |
| RadNet, Inc. (RDNT) | $5.87B | -285.0 |
| Charles River Laboratories International, Inc. (CRL) | $14.00B | -70.0 |
| UL Solutions Inc. (ULS) | $15.00B | 29.7 |
| Option Care Health, Inc. (OPCH) | $3.84B | 18.6 |
| Sotera Health Company (SHC) | $5.43B | 33.2 |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Pharmaceutical Products) | 17.1 |
QDEL overview · QDEL earnings · QDEL financials · QDEL KPIs · QDEL documents · QDEL ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.